News
-
REMEDI4ALL: an EU-funded research initiative to promote the repurposing of medicines in Europe
The platform has the potential to bring down times and costs of drug development by focusing on already approved, discontinued, shelved or investigational therapeutics.
-Read more-
-
Successes and Opportunities in Modeling & Simulation at FDA
In November 2022, the Modeling & Simulation Working Group of the FDA released a report of great importance for the in silico medicine community!
-Read more-
-
In the literature: November highlights
Click here to read some interesting recently published papers from our community. If you have published an article in the field of in silico medicine, send it to us: we will include it in this section of the newsletter!
-Read more-
-
Conference on pharmaceuticals impact on the environment
On 8 November 2022 a conference was held at the European Parliament on “Pharmaceuticals in the Environment: Current Challenges and Tomorrow's Solutions to Protect Wildlife”.
-Read more-
-
European institutions communicate their perspectives on AI in healthcare
The Centre for Artificial Intelligence under the European Parliament’s Science and Technology Options Assessment (STOA) Panel has published a podcast on AI in healthcare.
-Read more-
-
CPME puts forward its position on the EU pharma legislation revision
On 22 November 2022, the Standing Committee of European Doctors (CPME) has published its position on the revision of the EU general pharmaceutical legislation, urging the EU to restore the balance of the pharmaceutical sector in the interest of patients.
-Read more-
